London-based private equity firm Permira is buying out Lyophilization Services of New England (LSNE).

Nigeria has been looking for ways to get more drugs manufactured in the country while Servier’s generics unit Biogaran has been looking to expand. Now both…

The market for hepatitis C drugs is shrinking. Shortly after spending $3.9 billion on Idenix, Merck is taking a $2.9 billion hit on an experimental compound.

Sun Pharma’s Ranbaxy unit has started work on a manufacturing plant in Egypt, a project that got under way well before Sun bought Ranbaxy in 2015.

Charles River Laboratories has unloaded QS Pharma, a Philadelphia-area CDMO, months after picking it up as part of its $585 million buyout of WIL Research.

New Jersey-based CDMO Catalent grew its revenues in the second quarter but saw a significant fall in net earnings, but still beat analysts forecasts. It has…

France-based IBA Molecular has picked up two manufacturing sites, including one in the U.S., as part of its $690 million deal to buy the nuclear medicines…

Sun Pharma is said to be shopping its Ohm Laboratories plants in New Jersey as part of a manufacturing consolidation.

With its $830 million deal to buy Dendreon, Chinese conglomerate Sanpower Group takes on the expensive process of manufacturing prostate cancer vaccine…

M&A